Lemaitre Vascular (LMAT) Tops Q4 EPS by 2c, provides guidance
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $81.01 -0.87%
EPS Growth %: +12.9%
Financial Fact:
Provision for income taxes: 2.08M
Today's EPS Names:
VIVO, PMCB, PLCE, More
EPS Growth %: +12.9%
Financial Fact:
Provision for income taxes: 2.08M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.68, $0.02 better than the analyst estimate of $0.66. Revenue for the quarter came in at $64.45 million versus the consensus estimate of $62.98 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2026 revenue of $65.6-67.6 million, versus the consensus of $65.85 million.
Lemaitre Vascular sees FY2026 revenue of $276-284 million, versus the consensus of $270.5 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Subaru, other Japan suppliers to team on delivery as Boeing raises output - Nikkei
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
